Quantcast Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial - Congoo
 
 
WORLD Log In
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial
Have an interest in this Story?
Sign Up for Real-Time email updates
Pharmacy Choice  | November 07, 2009

CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ('Oncolytics' or the 'Company') today announced updated results from a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung in a poster presentation at the 15th Annual Connec...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Mark Palmer Mark Palmer
Founder
Internet consultancies
David Hood David Hood
Director
Marketing/Public Relations

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.